US Patent Issued to The Regents of the University of California on May 27 for "CRISPR-Cas effector polypeptides and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,616, issued on May 27, was assigned to The Regents of the University of California (Oakland, Calif.).

"CRISPR-Cas effector polypeptides and methods of use thereof" was invented by Jennifer A. Doudna (Berkeley, Calif.), Basem Al-Shayeb (Berkeley, Calif.), Jillian F. Banfield (Berkeley, Calif.) and Patrick Pausch (Berkeley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides RNA-guided CRISPR-Cas effector proteins, nucleic acids encoding same, and compositions comprising same. The present disclosure provides ribonucleoprotein complexes comprising: an RNA-guided CRISPR-Cas effector protein of the present disclosure; an...